research A Case of Atopic Dermatitis with Alopecia Universalis in a Patient Treated with Abrocitinib
Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.
Search
for
Sort by
Research
990-1000 / 1000+ resultsresearch Reversible Alopecia in Vogt-Koyanagi-Harada Disease and Sympathetic Ophthalmia
Alopecia can be reversed with timely steroid treatment in VKH and SO diseases.
research Expansion of Hair Follicle Stem Cells Sticking to Isolated Sebaceous Glands to Generate In Vivo Epidermal Structures
Sebaceous glands can help harvest hair follicle stem cells to regenerate skin and hair.
research Comparative Genomics of the Keratin-Associated Protein Gene Clusters in Human, Chimpanzee, and Baboon
KAP genes are crucial for hair development and show both shared and unique traits in humans, chimpanzees, and baboons.
research Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib
A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.
research CTLA4 +49AG (rs231775) And CT60 (rs3087243) Gene Variants Are Not Associated With Alopecia Areata In A Mexican Population From Monterrey, Mexico
CTLA4 gene variants are not linked to alopecia areata in Monterrey's Mexican population.
research Acute COVID-19 Syndrome Predicts Severe Long COVID-19: An Observational Study
Older, obese people with many COVID-19 symptoms are more likely to suffer from severe long-term COVID-19 effects.
research An Autopsy Case of Unicentric Castleman's Disease Associated with Bronchiolitis Obliterans
A woman with Castleman's disease died from respiratory failure due to bronchiolitis obliterans.
research New-Onset and Exacerbated Skin Diseases After COVID-19 Infection: A Systematic Review
COVID-19 infection can cause new hair loss conditions or worsen existing skin diseases, with hair loss being the most common issue.
research Low Neutralizing Antibody Titers After Asymptomatic or Non-Severe SARS-CoV-2 Infection Over a 6-Month Assessment Period
People with no symptoms or mild COVID-19 have lower antibody levels, increasing their risk of getting COVID-19 again.